Clinical Research

MS Research Roundup: April 18, 2014

Progress Toward New MS Clinical Trial Outcomes; Adaptive Design Evolves; A Call for Fundamental Neuroscience Research; MS Miracle Cures

Items of interest to multiple sclerosis researchers from around the Web...

Clinical Research, Drug Development, Laboratory Research, People

Antibody Testing Affects MS Therapy Management

In a randomized trial, access to antibody testing affected MS management. Serum binding antibodies predicted positivity to neutralizing antibodies in patients on high-dose interferon.

Access to antibody testing affected management in persons with multiple sclerosis, according to findings from...

Clinical Research

Stopping Natalizumab May Increase Risk of MS Relapse

The RESTORE trial showed that MRI and clinical MS activity recurred during natalizumab interruption in some patients who had been relapse-free for 1 year

Despite use of other therapies, magnetic resonance imaging and clinical activity of multiple sclerosis recurred during...

Clinical Research

MS Research Roundup: April 8, 2014

Medical Cannabis for MS; Rare Complication From Interferon-β; Genzyme to Try Again With Alemtuzumab; Retracted MS Paper

Items of interest to multiple sclerosis researchers from around the Web...

Clinical Research, Drug Development

PPMS: Predictors of Disease Progression Still Unknown

Failure to find reliable progression predictors makes individualized risk counseling difficult, highlights the shortcomings of the EDSS, and may complicate future PPMS clinical trials

None of the variables analyzed in a large cohort of patients with primary-progressive multiple sclerosis predicted...

Clinical Research

Rare Family Cluster of MS Reveals New Clues

Studying five affected siblings, researchers have learned that one version of a tumor suppressor gene may increase the risk of developing MS by 70%

An unexpected potential genetic risk factor for multiple sclerosis has been identified in a remarkable...

Clinical Research, People

MS Research Roundup: March 21, 2014

Tests of HIV Drug in Progress for RRMS; Statin Discovery in Progressive MS; Bench-to-Bedside MS Research Talks Online

Items of interest to multiple sclerosis researchers from around the Web...

Clinical Research, Drug Development, Meetings

Atacicept Phase 2 Trial Yields Disappointing Results for MS

Atacicept, which targets B cells, increased rather than decreased exacerbations in relapsing MS

Results from a phase 2 trial of the recombinant fusion protein atacicept raise significant questions about...

Clinical Research, Drug Development

Complementary/Alternative Medicine Use Changes With MS Progression

The transition from moderate to severe impairment is when many MS patients turn to complementary or alternative medicine

Persons with MS use complementary and alternative medicine most often during...

Clinical Research

American Society for Neurochemistry 2014

The American Society for Neurochemistry is meeting in Long Beach, California, 8-12 March 2014. Multiple Sclerosis Discovery Forum staffer Carol Cruzan Morton will be live tweeting from the event. Follow her tweets here or at @MSDForum.

Clinical Research, Drug Development, Laboratory Research, Meetings

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu

MS Research Roundup: April 18, 2014

Antibody Testing Affects MS Therapy Management

Stopping Natalizumab May Increase Risk of MS Relapse

MS Research Roundup: April 8, 2014

PPMS: Predictors of Disease Progression Still Unknown

Rare Family Cluster of MS Reveals New Clues

MS Research Roundup: March 21, 2014

Atacicept Phase 2 Trial Yields Disappointing Results for MS

Complementary/Alternative Medicine Use Changes With MS Progression

American Society for Neurochemistry 2014

Pages

MSDF Footer

Search form

Clinical Research

Pages